AB0017 Pilot Study on The Patterns of B Lymphocyts Infiltration in Kidney from Patients with Lupus Nephritis

BackgroundB lymphocytes infiltration associated ectopic lymphoid tissue (ELT) formation in situ kidney tissue had been showed to play an important role in the pathogenesis of MRL/lpr lupus nephritis mice model, until now there are few studies to identify the significance of them in the pathogenesis,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2016-06, Vol.75 (Suppl 2), p.902
Hauptverfasser: Dong, G.-F., Long, K.X.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Suppl 2
container_start_page 902
container_title Annals of the rheumatic diseases
container_volume 75
creator Dong, G.-F.
Long, K.X.
description BackgroundB lymphocytes infiltration associated ectopic lymphoid tissue (ELT) formation in situ kidney tissue had been showed to play an important role in the pathogenesis of MRL/lpr lupus nephritis mice model, until now there are few studies to identify the significance of them in the pathogenesis, diagnosis and treatment of human lupus nephritis (LN).ObjectivesTo know the significance of B lymphocytes infiltration and associated ectopic lymphoid tissue (ELT) formation in the pathogenesis, diagnosis and treatment of human LNMethodsThe renal specimen were analyzed by light microscopy examination of routine pathology and immunohistochemistry detection of CD3+,CD20+ and CD21+ cells expression. The enrolled patients were grouped based on the WHO classification of pathology or ELT patterns. Clinical datawere collected and evaluated.Results89 LN patients were experienced with GC and IS combination therapy and WHO III 21, WHO IV 53 and WHO V 15. 69 cases of CD20+ cells group and 20 of CD20-cells group could be divided. comparing to CD20-group, no difference could be founded in age, sex, blood leucocytes, urine protein, C3 level, C4 level, ESR, CRP, antiDNA, acute injury index and chronic injury index of renal tissue and total remission rate (all P>0.05), but significant difference can be found in mean disease duration (CD20+group: 21.8±9.9 months VS CD20-group: 9.8±6.2 months) (P=0.045) and complete disease remission rate (CD20+group: 63.8% VS CD20-group: 90%) (P=0.047) at 6 month of treatment. With respect to B lymphocytes infiltration associated ELT formation, there was focal distribution of CD3+ T cells and CD20+B cells (type 2) in 51 cases (57.3%), scattering distribution of CD3+ T cells and CD20+B cells (type 1) in 18 cases (20.2%) and no CD20+B cells infiltration in 20 cases (22.5%) but no expression of CD21+ dendritic cells expression in all. There was longer disease duration in type 2 patients than in type 1 or type 0 patients. compared to WHO V-LN patients, there was different ELT distribution patterns in WHO III and WHO IV-LN patients, but there were no difference in ELT distribution patterns between WHO III and WHO IV-LN patients.ConclusionsFocal distribution of CD3+ T cells and CD20+B cells (type 2 ELT)was main pattern in the renal interstitial tissue of LN patients. B cells infiltration-associated ELT formation is a predictor of longer disease duration and poor response to conventional combination therapy of high-dose GC and IS.AcknowledgementAcknow
doi_str_mv 10.1136/annrheumdis-2016-eular.5689
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1901860833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4322514759</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1273-8c78ad249ad71c35b9011c62f22bb78e74431f728d21c463ba33972080a2a803</originalsourceid><addsrcrecordid>eNqVkMtKxDAUhoMoOI6-Q2DWHXPpJCmuZsTLYNEBZx_SNqUZ2rQmKdKdG1_UJ7F1XLh1dTiH7_8PfAAsMFpiTNm1stZVum8K4yOCMIt0Xyu3XDGRnIAZjpkYzwydghlCiEZxwvg5uPD-MK5IYDEDdr1BCPOvj8-dqdsAX0NfDLC1cF9puFMhaGc9bEu4genQdFWbD8HDrS1NHZwKZiSNhU-msHqApWubKWS0HaF3EyqY9l3v4bPuKmeC8ZfgrFS111e_cw7293f728cofXnY3q7TKMOE00jkXKiCxIkqOM7pKksQxjkjJSFZxoXmcUxxyYkoCM5jRjNFacIJEkgRJRCdg8WxtnPtW699kIe2d3b8KPFYJRgSlI7UzZHKXeu906XsnGmUGyRGcvIr__iVk1_541dOfsc0O6az5vCv4DfSg4bo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901860833</pqid></control><display><type>article</type><title>AB0017 Pilot Study on The Patterns of B Lymphocyts Infiltration in Kidney from Patients with Lupus Nephritis</title><source>BMJ Journals - NESLi2</source><creator>Dong, G.-F. ; Long, K.X.</creator><creatorcontrib>Dong, G.-F. ; Long, K.X.</creatorcontrib><description>BackgroundB lymphocytes infiltration associated ectopic lymphoid tissue (ELT) formation in situ kidney tissue had been showed to play an important role in the pathogenesis of MRL/lpr lupus nephritis mice model, until now there are few studies to identify the significance of them in the pathogenesis, diagnosis and treatment of human lupus nephritis (LN).ObjectivesTo know the significance of B lymphocytes infiltration and associated ectopic lymphoid tissue (ELT) formation in the pathogenesis, diagnosis and treatment of human LNMethodsThe renal specimen were analyzed by light microscopy examination of routine pathology and immunohistochemistry detection of CD3+,CD20+ and CD21+ cells expression. The enrolled patients were grouped based on the WHO classification of pathology or ELT patterns. Clinical datawere collected and evaluated.Results89 LN patients were experienced with GC and IS combination therapy and WHO III 21, WHO IV 53 and WHO V 15. 69 cases of CD20+ cells group and 20 of CD20-cells group could be divided. comparing to CD20-group, no difference could be founded in age, sex, blood leucocytes, urine protein, C3 level, C4 level, ESR, CRP, antiDNA, acute injury index and chronic injury index of renal tissue and total remission rate (all P&gt;0.05), but significant difference can be found in mean disease duration (CD20+group: 21.8±9.9 months VS CD20-group: 9.8±6.2 months) (P=0.045) and complete disease remission rate (CD20+group: 63.8% VS CD20-group: 90%) (P=0.047) at 6 month of treatment. With respect to B lymphocytes infiltration associated ELT formation, there was focal distribution of CD3+ T cells and CD20+B cells (type 2) in 51 cases (57.3%), scattering distribution of CD3+ T cells and CD20+B cells (type 1) in 18 cases (20.2%) and no CD20+B cells infiltration in 20 cases (22.5%) but no expression of CD21+ dendritic cells expression in all. There was longer disease duration in type 2 patients than in type 1 or type 0 patients. compared to WHO V-LN patients, there was different ELT distribution patterns in WHO III and WHO IV-LN patients, but there were no difference in ELT distribution patterns between WHO III and WHO IV-LN patients.ConclusionsFocal distribution of CD3+ T cells and CD20+B cells (type 2 ELT)was main pattern in the renal interstitial tissue of LN patients. B cells infiltration-associated ELT formation is a predictor of longer disease duration and poor response to conventional combination therapy of high-dose GC and IS.AcknowledgementAcknowledgement to pathologist professor Ping Mei and the statistian He LiDisclosure of InterestNone declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2016-eular.5689</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><ispartof>Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.902</ispartof><rights>2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/75/Suppl_2/902.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/75/Suppl_2/902.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3182,23551,27903,27904,77346,77377</link.rule.ids></links><search><creatorcontrib>Dong, G.-F.</creatorcontrib><creatorcontrib>Long, K.X.</creatorcontrib><title>AB0017 Pilot Study on The Patterns of B Lymphocyts Infiltration in Kidney from Patients with Lupus Nephritis</title><title>Annals of the rheumatic diseases</title><description>BackgroundB lymphocytes infiltration associated ectopic lymphoid tissue (ELT) formation in situ kidney tissue had been showed to play an important role in the pathogenesis of MRL/lpr lupus nephritis mice model, until now there are few studies to identify the significance of them in the pathogenesis, diagnosis and treatment of human lupus nephritis (LN).ObjectivesTo know the significance of B lymphocytes infiltration and associated ectopic lymphoid tissue (ELT) formation in the pathogenesis, diagnosis and treatment of human LNMethodsThe renal specimen were analyzed by light microscopy examination of routine pathology and immunohistochemistry detection of CD3+,CD20+ and CD21+ cells expression. The enrolled patients were grouped based on the WHO classification of pathology or ELT patterns. Clinical datawere collected and evaluated.Results89 LN patients were experienced with GC and IS combination therapy and WHO III 21, WHO IV 53 and WHO V 15. 69 cases of CD20+ cells group and 20 of CD20-cells group could be divided. comparing to CD20-group, no difference could be founded in age, sex, blood leucocytes, urine protein, C3 level, C4 level, ESR, CRP, antiDNA, acute injury index and chronic injury index of renal tissue and total remission rate (all P&gt;0.05), but significant difference can be found in mean disease duration (CD20+group: 21.8±9.9 months VS CD20-group: 9.8±6.2 months) (P=0.045) and complete disease remission rate (CD20+group: 63.8% VS CD20-group: 90%) (P=0.047) at 6 month of treatment. With respect to B lymphocytes infiltration associated ELT formation, there was focal distribution of CD3+ T cells and CD20+B cells (type 2) in 51 cases (57.3%), scattering distribution of CD3+ T cells and CD20+B cells (type 1) in 18 cases (20.2%) and no CD20+B cells infiltration in 20 cases (22.5%) but no expression of CD21+ dendritic cells expression in all. There was longer disease duration in type 2 patients than in type 1 or type 0 patients. compared to WHO V-LN patients, there was different ELT distribution patterns in WHO III and WHO IV-LN patients, but there were no difference in ELT distribution patterns between WHO III and WHO IV-LN patients.ConclusionsFocal distribution of CD3+ T cells and CD20+B cells (type 2 ELT)was main pattern in the renal interstitial tissue of LN patients. B cells infiltration-associated ELT formation is a predictor of longer disease duration and poor response to conventional combination therapy of high-dose GC and IS.AcknowledgementAcknowledgement to pathologist professor Ping Mei and the statistian He LiDisclosure of InterestNone declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkMtKxDAUhoMoOI6-Q2DWHXPpJCmuZsTLYNEBZx_SNqUZ2rQmKdKdG1_UJ7F1XLh1dTiH7_8PfAAsMFpiTNm1stZVum8K4yOCMIt0Xyu3XDGRnIAZjpkYzwydghlCiEZxwvg5uPD-MK5IYDEDdr1BCPOvj8-dqdsAX0NfDLC1cF9puFMhaGc9bEu4genQdFWbD8HDrS1NHZwKZiSNhU-msHqApWubKWS0HaF3EyqY9l3v4bPuKmeC8ZfgrFS111e_cw7293f728cofXnY3q7TKMOE00jkXKiCxIkqOM7pKksQxjkjJSFZxoXmcUxxyYkoCM5jRjNFacIJEkgRJRCdg8WxtnPtW699kIe2d3b8KPFYJRgSlI7UzZHKXeu906XsnGmUGyRGcvIr__iVk1_541dOfsc0O6az5vCv4DfSg4bo</recordid><startdate>201606</startdate><enddate>201606</enddate><creator>Dong, G.-F.</creator><creator>Long, K.X.</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201606</creationdate><title>AB0017 Pilot Study on The Patterns of B Lymphocyts Infiltration in Kidney from Patients with Lupus Nephritis</title><author>Dong, G.-F. ; Long, K.X.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1273-8c78ad249ad71c35b9011c62f22bb78e74431f728d21c463ba33972080a2a803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dong, G.-F.</creatorcontrib><creatorcontrib>Long, K.X.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dong, G.-F.</au><au>Long, K.X.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AB0017 Pilot Study on The Patterns of B Lymphocyts Infiltration in Kidney from Patients with Lupus Nephritis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2016-06</date><risdate>2016</risdate><volume>75</volume><issue>Suppl 2</issue><spage>902</spage><pages>902-</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>BackgroundB lymphocytes infiltration associated ectopic lymphoid tissue (ELT) formation in situ kidney tissue had been showed to play an important role in the pathogenesis of MRL/lpr lupus nephritis mice model, until now there are few studies to identify the significance of them in the pathogenesis, diagnosis and treatment of human lupus nephritis (LN).ObjectivesTo know the significance of B lymphocytes infiltration and associated ectopic lymphoid tissue (ELT) formation in the pathogenesis, diagnosis and treatment of human LNMethodsThe renal specimen were analyzed by light microscopy examination of routine pathology and immunohistochemistry detection of CD3+,CD20+ and CD21+ cells expression. The enrolled patients were grouped based on the WHO classification of pathology or ELT patterns. Clinical datawere collected and evaluated.Results89 LN patients were experienced with GC and IS combination therapy and WHO III 21, WHO IV 53 and WHO V 15. 69 cases of CD20+ cells group and 20 of CD20-cells group could be divided. comparing to CD20-group, no difference could be founded in age, sex, blood leucocytes, urine protein, C3 level, C4 level, ESR, CRP, antiDNA, acute injury index and chronic injury index of renal tissue and total remission rate (all P&gt;0.05), but significant difference can be found in mean disease duration (CD20+group: 21.8±9.9 months VS CD20-group: 9.8±6.2 months) (P=0.045) and complete disease remission rate (CD20+group: 63.8% VS CD20-group: 90%) (P=0.047) at 6 month of treatment. With respect to B lymphocytes infiltration associated ELT formation, there was focal distribution of CD3+ T cells and CD20+B cells (type 2) in 51 cases (57.3%), scattering distribution of CD3+ T cells and CD20+B cells (type 1) in 18 cases (20.2%) and no CD20+B cells infiltration in 20 cases (22.5%) but no expression of CD21+ dendritic cells expression in all. There was longer disease duration in type 2 patients than in type 1 or type 0 patients. compared to WHO V-LN patients, there was different ELT distribution patterns in WHO III and WHO IV-LN patients, but there were no difference in ELT distribution patterns between WHO III and WHO IV-LN patients.ConclusionsFocal distribution of CD3+ T cells and CD20+B cells (type 2 ELT)was main pattern in the renal interstitial tissue of LN patients. B cells infiltration-associated ELT formation is a predictor of longer disease duration and poor response to conventional combination therapy of high-dose GC and IS.AcknowledgementAcknowledgement to pathologist professor Ping Mei and the statistian He LiDisclosure of InterestNone declared</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1136/annrheumdis-2016-eular.5689</doi></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.902
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1901860833
source BMJ Journals - NESLi2
title AB0017 Pilot Study on The Patterns of B Lymphocyts Infiltration in Kidney from Patients with Lupus Nephritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T14%3A41%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AB0017%E2%80%85Pilot%20Study%20on%20The%20Patterns%20of%20B%20Lymphocyts%20Infiltration%20in%20Kidney%20from%20Patients%20with%20Lupus%20Nephritis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Dong,%20G.-F.&rft.date=2016-06&rft.volume=75&rft.issue=Suppl%202&rft.spage=902&rft.pages=902-&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2016-eular.5689&rft_dat=%3Cproquest_cross%3E4322514759%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1901860833&rft_id=info:pmid/&rfr_iscdi=true